Greg Curfman

  • Read more: King v. Burwell And A Right To Health Care

    King v. Burwell And A Right To Health Care

    By Gregory Curfman Bill of Health contributor Gregory Curfman has a new piece up at the Health Affairs Blog discussing the Supreme Court’s decision in King v. Burwell in the broader context of Americans’ right to care. From the piece: Do Americans have a fundamental right to health care? This oft-debated question is timely given the Supreme Court’s stunning…

  • Read more: Health Law Year in P/Review: Until Next Year

    Health Law Year in P/Review: Until Next Year

    By Holly F. Lynch, I. Glenn Cohen, and Gregory Curfman This new post by Holly F. Lynch, I. Glenn Cohen, and Gregory Curfman appears on the Health Affairs Blog as the final entry in a series stemming from the Third Annual Health Law Year in P/Review event held at Harvard Law School on Friday, January 30, 2015. It’s been our great pleasure…

  • Read more: Last Year Was A Wild One For Health Law — What’s On The Docket For 2015?

    Last Year Was A Wild One For Health Law — What’s On The Docket For 2015?

    By Greg Curfman, Holly Fernandez Lynch and I. Glenn Cohen This new blog post by Greg Curfman, Holly Fernandez Lynch and I. Glenn Cohen appears on the Health Affairs Blog: Everywhere we look, we see the tremendous impact of new legal developments—whether regulatory or statutory, federal or state—on health and health care. These topics range from insurance to intellectual…

  • Read more: Introducing Greg Curfman

    Introducing Greg Curfman

    We’re pleased to formally introduce Dr. Greg Curfman as a contributor to Bill of Health. Dr. Curfman is already a familiar face here as a regular guest, and we’re thrilled to officially welcome him. Dr. Curfman is currently editor in chief of Harvard Health Publications at Harvard Medical School. Previously he was executive director of the New England Journal…

  • Read more: A Mixed Message on Obamacare from Two Federal Circuits

    A Mixed Message on Obamacare from Two Federal Circuits

    By Greg Curfman and Holly Fernandez Lynch It was as if lightning had struck twice in the same place. On Tuesday two pivotal federal circuit court opinions that could dramatically impact the future of Obamacare were unexpectedly issued within hours of each other. And what’s more, the two opinions reached opposite conclusions on the same…

  • Read more: Justice Breyer and Wheaton College v. Burwell

    Justice Breyer and Wheaton College v. Burwell

    By Gregory Curfman Tom Goldstein, Publisher of SCOTUSblog, has opined on why Justice Stephen Breyer apparently joined the majority opinion in Wheaton College v. Burwell, which the Court released last Thursday. The majority granted Wheaton a temporary injunction exempting the College from the contraceptive mandate, which was spawned by the Affordable Care Act and which…

  • Read more: In the Aftermath of Hobby Lobby

    In the Aftermath of Hobby Lobby

    By Gregory Curfman and Holly Fernandez Lynch [A quick follow up to our recent NEJM Perspective on the case, with I. Glenn Cohen] Immediately after Justice Samuel Alito’s announcement on June 30 of the majority opinion in Burwell v. Hobby Lobby, the Supreme Court took further actions on the contraceptive mandate, and both supporters and opponents…

  • Read more: Religious Freedom and Access to Health Care

    Religious Freedom and Access to Health Care

    By I. Glenn Cohen, Holly Fernandez Lynch, and Gregory Curfman Check out the “hot off the press” New England Journal of Medicine Perspectives piece “When Religious Freedom Clashes with Access to Care” by Petrie-Flom Faculty Director I. Glenn Cohen, Executive Director Holly Fernandez Lynch, and NEJM Executive Editor (and PFC Faculty Affiliate), Gregory Curfman.  We review the…

  • Read more: On Access and Accountability: Two Supreme Court Rulings on Generic Drugs

    On Access and Accountability: Two Supreme Court Rulings on Generic Drugs

    By Marcia Boumil and Gregory Curfman In 2013 the U.S. Supreme Court issued two important rulings in cases involving the marketing of generic drugs. In Federal Trade Commission v. Actavis, the Court addressed the law governing a controversial pharmaceutical marketing practice known as reverse payment agreements, or pay for delay – a byproduct of the Hatch-Waxman…